Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Bitcoin Trust
IBIT
|
+$844M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$807M |
| 3 |
Merck
MRK
|
+$531M |
| 4 |
CRH
CRH
|
+$462M |
| 5 |
Amazon
AMZN
|
+$431M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.54B |
| 2 |
Microsoft
MSFT
|
+$1B |
| 3 |
NVIDIA
NVDA
|
+$651M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$569M |
| 5 |
Micron Technology
MU
|
+$470M |
Sector Composition
| 1 | Technology | 17.02% |
| 2 | Healthcare | 13.82% |
| 3 | Financials | 11.94% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Castle Biosciences
CSTL
$621M
| $5.51M | ﹤0.01% |
248,553
-467,797
| -65% | -$10.4M |
|
1802
Nurix Therapeutics
NRIX
$691M
| $5.5M | ﹤0.01% |
374,249
-3,339
| -0.9% | -$49.1K |
|
1803
Cricut
CRCT
$1.4B
| $5.5M | ﹤0.01% |
1,154,602
+272,634
| +31% | +$1.3M |
|
1804
New Mountain Finance
NMFC
$1.11B
| $5.49M | ﹤0.01% |
433,405
-68,862
| -14% | -$872K |
|
1805
Exelixis
EXEL
$10.5B
| $5.48M | ﹤0.01% |
230,979
-1,252,193
| -84% | -$29.7M |
|
1806
Korro Bio
KRRO
$289M
| $5.48M | ﹤0.01% |
+60,894
| New | +$5.48M |
|
1807
Frontdoor
FTDR
$4.83B
| $5.48M | ﹤0.01% |
168,193
-317,933
| -65% | -$10.4M |
|
1808
Shattuck Labs
STTK
$92M
| $5.47M | ﹤0.01% |
612,384
+601,738
| +5,652% | +$5.38M |
|
1809
FormFactor
FORM
$2.32B
| $5.46M | ﹤0.01% |
119,621
+74,151
| +163% | +$3.38M |
|
1810
Saic
SAIC
$4.9B
| $5.44M | ﹤0.01% |
41,708
+35,100
| +531% | +$4.58M |
|
|
TBCH
1811
Turtle Beach Corporation Common Stock
TBCH
$299M
| $5.43M | ﹤0.01% |
315,200
+123,598
| +65% | +$2.13M |
|
1812
Moog
MOG.A
$6.27B
| $5.43M | ﹤0.01% |
34,031
-27,951
| -45% | -$4.46M |
|
|
ALTR
1813
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $5.42M | ﹤0.01% |
62,900
-59,940
| -49% | -$5.16M |
|
1814
Matrix Service
MTRX
$353M
| $5.41M | ﹤0.01% |
415,130
+138,158
| +50% | +$1.8M |
|
1815
Resideo Technologies
REZI
$5.66B
| $5.4M | ﹤0.01% |
241,032
-124,644
| -34% | -$2.79M |
|
|
RGLS
1816
DELISTED
Regulus Therapeutics
RGLS
| $5.4M | ﹤0.01% |
+1,875,226
| New | +$5.4M |
|
1817
Macerich
MAC
$4.58B
| $5.39M | ﹤0.01% |
312,973
+51,908
| +20% | +$894K |
|
1818
Ball Corp
BALL
$13.9B
| $5.39M | ﹤0.01% |
80,014
-697,928
| -90% | -$47M |
|
|
INZY
1819
DELISTED
Inozyme Pharma
INZY
| $5.39M | ﹤0.01% |
703,606
-207,859
| -23% | -$1.59M |
|
1820
Danaos Corp
DAC
$1.73B
| $5.38M | ﹤0.01% |
74,566
-51,309
| -41% | -$3.7M |
|
1821
Ouster
OUST
$1.67B
| $5.38M | ﹤0.01% |
677,955
+166,245
| +32% | +$1.32M |
|
1822
Fastly
FSLY
$1.14B
| $5.38M | ﹤0.01% |
414,861
+228,725
| +123% | +$2.97M |
|
1823
Build-A-Bear
BBW
$971M
| $5.38M | ﹤0.01% |
180,015
-164,067
| -48% | -$4.9M |
|
1824
Cavco Industries
CVCO
$4.32B
| $5.37M | ﹤0.01% |
13,469
-25,250
| -65% | -$10.1M |
|
1825
Halozyme
HALO
$8.99B
| $5.37M | ﹤0.01% |
132,068
-178,838
| -58% | -$7.28M |
|